BREAKING: Senate Investigation Reveals Inhaler Companies Charge Americans 12x More — While Suppressing a $33 Natural Alternative
By Health Desk | May 2, 2026
A Senate investigation has uncovered what millions of COPD patients suspected:
Pharmaceutical companies have been systematically price-gouging Americans on inhalers.
Up to 1,200% more than patients in other countries pay for the exact same product.
The Price Gouging — In Black and White
| Inhaler | US Price | International | Markup |
|---|---|---|---|
| Advair (GSK) | $319 | $26 (UK) | 1,227% |
| QVAR (Teva) | $286 | $9 (Germany) | 3,178% |
| Combivent | $489 | $7 (France) | 6,986% |
Combined revenue — AstraZeneca, GSK, Teva — past 5 years:
Over $25 billion.
From products that provide temporary relief. At best.
But It Gets Worse
The investigation reveals something even more disturbing:
These companies have known for decades that inhalers don't address the root cause of COPD.
And that natural botanical compounds CAN.
They chose profit over patients.
The Root Cause They're Ignoring
COPD symptoms aren't from "irreversible lung damage."
They're from a paralyzed cleaning system — millions of cilia that stopped sweeping mucus out.
Inhalers don't fix cilia. They force airways open for 4 hours.
When they wear off: cilia still broken, mucus still there, back to square one.
A treatment that fixes the root cause = sold once.
A treatment that lasts 4 hours = sold every day, every month, for life.
Recurring revenue. Lifetime customers.
The business model depends on your lungs staying broken.
The Suppressed Science
Published. Peer-reviewed. Available to anyone who looks:
- Thyme extract stimulates ciliary beat frequency. COPD Journal: "therapeutic use for COPD."
- Mullein leaf benefits the respiratory tract. Cleveland Clinic-acknowledged.
- Oregano oil recognized by European Medicines Agency as expectorant.
- Marshmallow root decreases cough frequency within minutes.
Not alternative pseudoscience.
Published clinical research.
So why hasn't your doctor mentioned it?
1. Medical education funded by pharma
2. Can't patent natural compounds = no marketing budget
3. Healed patients stop buying inhalers
One Doctor Broke Ranks
Dr. Marcus T. — board-certified pulmonologist, 18 years.
He formulated a concentrated spray delivering these compounds directly to airways.
Called it Airwell™.
Price: $33.33. Buy one, get one free. 60-day guarantee.
For comparison: one day of the average COPD patient's annual spending ($12,108/yr) = $33.17.
What 47,000 Users Report
★★★★★ — "One $33 spray did what $8,000 in prescriptions couldn't." — Robert K., 61
★★★★★ — "Costs less than one copay — and actually works." — Margaret S., 72
★★★★★ — "Doctor billed $489 for the visit. Airwell cost $33. Do the math." — James W., 55
The Numbers Don't Lie
Annual cost of "managing" COPD:
- Inhalers: $7,000-9,000
- Specialists: $1,200-2,400
- Nebulizer: $1,800-2,400
- Hospital: $10,000-30,000/event
- Average total: $12,108/year
Cost of Airwell: $33.33 (with BOGO free)
Risk: Zero. 60-day money-back guarantee.
What You Can Do Right Now
The pharmaceutical industry wants you compliant and paying $500+/month.
You don't have to accept that.
- $33.33 (60% off)
- Buy 1, Get 1 FREE
- 60-day money-back guarantee
- Free shipping
- Official website only
A $33 spray that works is the biggest threat to $25 billion in revenue.
Get it while it's available.
- 60-Day Money Back Guarantee
- Guaranteed Safe and Secure Checkout
- No-Hassle Returns
- Free Shipping
60-Day Unconditional Money-Back Guarantee
Try Airwell™ for a full 60 days. If you don’t notice a real difference in your breathing — less coughing, better sleep, clearer airways — you get every single penny back. No questions asked. No forms. No hassle. You email us, we refund you. Same day. Zero risk.